Beta 2-microglobulin generation and removal in long slow and short fast hemodialysis.
We studied the influence of different modes of hemodialysis (HD) on plasma levels of beta 2-microglobulin (P-beta 2-m) and its correlation to changes in leukocyte count, complement activation (C3a), and elastase generation. The influence of dialyzer membrane, membrane surface area, duration of treatment, and blood flow was analyzed with respect to post-HD levels of P-beta 2-m. Twenty patients underwent 12 modes of bicarbonate hemodialysis in random order (n = 252) using three different membranes (Cuprophan [CU], hemophan [HE], or polyamide [PA], two dialyzer areas, and fast (400 mL/min) or slow (200 mL/min) blood flow (Qb) for 2 or 4 hours, respectively. All dialysate was collected and beta 2-m was analyzed (D-beta 2-m). After correction for hemoconcentration, P-beta 2-m concentrations were found to have decreased significantly during treatment with all three membranes (CU, 0.9 +/- 0.3 mg/L, P = 0.002; HE, 1.2 +/- 0.3 mg/L, P < 0.001; and PA, 8.3 +/- 0.3 mg/L, P < 0.001). Elimination of P-beta 2-m was influenced by type of membrane (P < 0.001) and ultrafiltration volume (P = 0.0019) but not by membrane area or Qb. The largest reduction in P-beta 2-m (-10.4 mg/L) was achieved by the following treatment combination: PA membrane, large dialyzer area, and low Qb for 4 hours. P-beta 2-m decreased more during PA dialysis at low Qb for 4 hours (-9.9 +/- 0.5 mg/L) than during high Qb for 2 hours (-6.8 +/- 0.5 mg/L, P < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
Skroeder
N R
NR
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Jacobson
S H
SH
Holmquist
B
B
Kjellstrand
P
P
Kjellstrand
C M
CM
D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000209:etiology / Q000378:metabolism; D001639:Bicarbonates; D003167:Complement Activation; D015314:Dialysis Solutions / Q000737:chemistry; D005260:Female; D006801:Humans; D007970:Leukopenia; D008297:Male; D008875:Middle Aged; D010196:Pancreatic Elastase / Q000096:biosynthesis; D012044:Regression Analysis; D006435:Renal Dialysis / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000032:analysis / Q000378:metabolism*
D001639:Bicarbonates; D015314:Dialysis Solutions; D001613:beta 2-Microglobulin; D010196:Pancreatic Elastase